Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
413.65
Change Change %
-1.00 -0.24%

Updated:19 Feb, 2019, 15:59 PM IST

BSE
414.35
Change Change %
-0.75 -0.18%

Updated:19 Feb, 2019, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Nomura
N/A
14-08-2017 Hold 452.00 600.00
N/A
Target Hit Long (1Y)
14-08-2018

Nomura maintains neutral on Sun Pharmaceuticals

Sun Pharma's earnings were materially lower than our estimates with sales and EBITDA missing our estimates by 8% and 27%, respectively. The slowdown in India (-5% y-y) is largely along expected lines. However, US revenues came in lower on higher pricing pressure. Management guided for single digit revenue decline in FY18F and EBITDA margin expanding to just 20-22% by 2HFY18F. This indicates continued pressure in the business in the near term.

Top